+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Global Clinical Trial Support Services Market - Growth, Trends and Forecasts 2017 - 2022

  • ID: 4388363
  • Report
  • Region: Global
  • 205 pages
  • Mordor Intelligence
1 of 4
The Global Clinical Trial Support Services Market is estimated to be $ xx billion for the year 2015 to reach $ xx billion by the year 2020. The CAGR with which market is growing is anticipated to be x.x%.

The clinical trial support services provide the preclinical ground work and research such as patient recruitment, supporting clinical trial sites, procuring and storage of study medications, blinding of study drug, coordination and reconciliation of return medications, Calculation of specific dosing, Lab kit handling, labeling, distribution and follow-up, coordination, training with study sites, dispensing/distribution of study drug to appropriate sites, inventory and distribution of supplies and equipment, packaging and labeling. The key driver for the growth of this market is increasing interest of pharmaceutical companies investing in the production and sponsor of clinical trials and drug development. Growing demand of drug development and increasing prevalence of the diseases elevates the clinical trial support services market. But due to increasing pressure on the development cycle of clinical trial i.e. from patient recruitment to analyzing big data, companies has to consider these factors for investment. It is also observed an increasing opportunity for clinical research organizations. Major pharmerging countries such as Brazil, Russia, India are also encouraging the clinical trial support services.

The global clinical trial support services market is segmented based on phase of the clinical trial cycle such as preclinical studies, Phase I, Phase II, Phase III and Phase IV, by study design which includes observational studies and experimental studies, by the services provided such as patient recruitment management, assay Development, clinical research organizations, clinical trial site management and by geography. The geographical regions considered include North America, Europe, Latin America, Middle East Asia and Asia Pacific. The clinical trial support services regulations differs from region to region.

The major companies in this market are Alcura Health, Quintiles, Parexel, Pharmaceutical Product Development, LLC, Covance, ICON Plc

This report offers comprehensive profiles of these companies composed of their business strategy for biosimilars, financials, SWOT analysis, products and services and the insightful company analysis by our analyst.

This Report Offers:

Market Definition for the specified topic along with identification of key drivers and restraints for the market.
Market analysis for the Global Clinical Trial Support Service Market, with region specific assessments and competition analysis on a global and regional scale.
Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market shares.
Identification and analysis of the Macro and Micro factors that affect the Global Biosimilars market on both global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
Note: Product cover images may vary from those shown
2 of 4
1. Introduction
1.1 Study Deliverables
1.2 Market Definition
1.3 Sizing Units
1.4 Base Currency
1.5 Review and Forecast Period Years
1.6 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Analysis Methodology
2.3 Econometric Forecast Model
2.4 Research Assumptions
3. Executive Summary
4. Key Inferences
5. Market Overview and Industry Trends
5.1 Current Market Scenario
5.2 Clinical Trial Support Services Overview
5.2.1 New Developments
5.2.2 Market Trends
5.2.3 Clinical Trial Outsourcing
5.2.4 Preferred Clinical Research Organizations
5.2.5 Clinical Trial Site Management and Support
5.2.6 Trial Investigator Education
5.2.7 Trial Laboratory Certification
5.3 Porter’s Five Forces
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Consumers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitute Products and Services
5.3.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Increasing R&D Investments
6.1.2 Growing demand for Drug Development
6.1.3 Increasing Prevalence of Diseases
6.2 Market Restraints
6.2.1 Increasing pressure on the development cycle – from patient recruitment to analyzing big data
6.2.2 Regulatory reforms including time period for clinical trial approvals
6.3 Current Opportunities
6.3.1 Clinical Research Organizations
6.3.2 Pharmerging Markets
7. Global Clinical Trial Support Services Market, by Phases
7.1 Preclinical Studies
7.2 Phase I
7.3 Phase II
7.4 Phase III
7.5 Phase IV
8. Global Clinical Trials Support Services Market, by Study Designs
8.1 Observational Studies
8.2 Experimental Studies
9. Global Clinical Trials Support Services Market, by Services
9.1 Patient Recruitment Management
9.2 Assay Development
9.3 Clinical Research Organizations
9.4 Clinical Trial Site Management
10. Global Clinical Trials Support Services Market, Regulatory Landscape
11. Global Industry of Things Market, by Geography – Regional Share and Forecasts
11.1 North America (NA)
11.1.1 Introduction
11.1.2 United States
11.1.3 Canada
11.1.4 Rest of North America
11.2 Europe
11.2.1 Introduction
11.2.2 Germany
11.2.3 United Kingdom
11.2.4 France
11.2.5 Italy
11.2.6 Spain
11.2.7 Russia
11.2.8 Rest of the Europe
11.3 Asia-Pacific (APAC)
11.3.1 Introduction
11.3.2 China
11.3.3 Japan
11.3.4 India
11.3.5 Australia
11.3.6 South Korea
11.3.7 Rest of Asia-Pacific
11.4 Middle-East and Africa (MEA)
11.4.1 Introduction
11.4.2 UAE
11.4.3 Saudi Arabia
11.6.4 Israel
11.6.5 Rest of the MEA
11.5 Latin America
11.6.1 Introduction
11.6.2 Brazil
11.6.3 Argentina
11.6.4 Mexico
11.6.5 Rest of Latin America
12. Competitive Landscape
12.1 Merger and Acquisition Analysis
12.2 The Challengers
13. Key Vendor Analysis
13.1 Alcura Health
13.2 Quintiles
13.3 Parexel
13.4 Pharmaceutical Product Development, LLC
13.5 Covance
13.6 ICON Plc
13.7 Quotient Bioresearch
13.8 Charles River Laboratories
13.9 Pharmnet
13.10 WuXi
13.11 Accovion
14. Analyst Outlook for Investment Opportunities
15. Future Outlook of the Market
Note: Product cover images may vary from those shown
3 of 4


4 of 4